1e
19
1
49
2
2
18
1b
1d
18
2e
9d
1d
2 29
1d
25
Gregory Tino, MD
78
9d
Associate Professor of Medicine (Pulmonary, Allergy and Critical Care) at the Hospital of the University of Pennsylvania
28
a3
3
5f
Attending Physician, Presbyterian Medical Center, University of Pennsylvania Health System, Philadelphia, PA
63
Chair, Hospital of the University of Pennsylvania
33
Pulmonary, Allergy & Critical Care Division
df
Physician Messenger, Penn Patient Advocacy Reporting Program (PARS), Patient Complaint Monitoring Committee, University of Pennsylvania Health System, Philadelphia, PA
8a
Chief, Department of Medicine, Penn Presbyterian Medical Center, Philadelphia, PA
b2
Senior Vice Chair, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
85
President-elect, Medical Executive Committee, Penn Presbyterian Medical Center
82
Chair, 2018 Bach Fund Selection Committee, Penn Presbyterian Medical Center
62
Official Medical Consultant, Penn Athletics
93
Past President, Medical Staff, Medical Executive Committee, Penn Presbyterian Medical Center
11
Department: Medicine
4
1
b
1d
46
Contact information
4e
4
3
3
3
2
4
b
1f
4e
Penn Presbyterian Medical Center
1d 39th & Market Streets
4a Department of Medicine, Suite W130
Philadelphia, PA 19104-2699
26
1d 39th & Market Streets
4a Department of Medicine, Suite W130
Philadelphia, PA 19104-2699
2e
Office: 215-662-8989
32 Fax: 215-243-3208
24
a7
12
32 Fax: 215-243-3208
24
13
Education:
21 9 B.A. 26 (Biology/Political Science) c
4f Columbia College of Columbia University, New York, NY , 1982.
21 9 M.D. c
43 Mt. Sinai School of Medicine, New York, NY, 1986.
c
3
3
3
3
8b
Permanent link21 9 B.A. 26 (Biology/Political Science) c
4f Columbia College of Columbia University, New York, NY , 1982.
21 9 M.D. c
43 Mt. Sinai School of Medicine, New York, NY, 1986.
c
2 29
21
1e
1d
24
2b
29
27
23
109 National Emphysema Treatment Trial Research Group (Tino, G, member) : Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 348: 2092-2102, 2003.
143 Ahya VN, Tino G, Fiel S.: Management of bronchiectasis and cystic fibrosis. In: Management of Non-neoplastic Advanced Lung Disease. Edited by, Lung Biology in Health and Disease Series. JR Maurer (eds.). Marcel-Dekker, New York Page: 339-386, 2003.
120 Lipson D, Tino G: Pleurisy. Physicians’ Information and Education Resource (PIER), Philadelphia, PA, American College of Physicians- American Society of Internal Medicine. Editor-in-Chief, D Goldmann (eds.). 2002.
17c Ahya VN, Nguyen BT, Blumenthal NP, Pocchettino A, Lipson DA, Gefter WB, Christie JD, Tino G, Zisman DA, Kotloff RM: Radiographic improvement of native lung idiopathic pulmonary fibrosis after single lung transplantation. Chest 122: 76S, 2002 Notes: CHEST 2002 Annual Meeting. Accepted for oral presentation.
d9 Zisman DA, McCune WJ, Tino G, Lynch JP: Drug-induced pneumonitis: The role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis 18: 243-252, 2001.
133 Kotloff RM, Hansen-Flaschen J, Lipson DA, Tino G, Arcasoy SM, Alavi A, Kaiser LR: Apical perfusion fraction as a predictor of short term functional outcome following bilateral lung volume reduction surgery. Chest 120: 1609-1615, 2001.
f4 National Emphysema Treatment Trial Research Group (Tino, G, member): Patients at high risk of death after lung-volume-reduction-surgery. N Engl J Med 345: 1075-1084, 2001.
ae Arcasoy SM, Tino G: Clinical aspects of obstructive lung disease. Semin Roentgenol XXXVI: 6-11, 2001.
2c
7
1d
1f
Selected Publications
116 National Emphysema Treatment Trial Research Group (Tino, G, member): A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348: 2059-2073, 2003.109 National Emphysema Treatment Trial Research Group (Tino, G, member) : Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 348: 2092-2102, 2003.
143 Ahya VN, Tino G, Fiel S.: Management of bronchiectasis and cystic fibrosis. In: Management of Non-neoplastic Advanced Lung Disease. Edited by, Lung Biology in Health and Disease Series. JR Maurer (eds.). Marcel-Dekker, New York Page: 339-386, 2003.
120 Lipson D, Tino G: Pleurisy. Physicians’ Information and Education Resource (PIER), Philadelphia, PA, American College of Physicians- American Society of Internal Medicine. Editor-in-Chief, D Goldmann (eds.). 2002.
17c Ahya VN, Nguyen BT, Blumenthal NP, Pocchettino A, Lipson DA, Gefter WB, Christie JD, Tino G, Zisman DA, Kotloff RM: Radiographic improvement of native lung idiopathic pulmonary fibrosis after single lung transplantation. Chest 122: 76S, 2002 Notes: CHEST 2002 Annual Meeting. Accepted for oral presentation.
d9 Zisman DA, McCune WJ, Tino G, Lynch JP: Drug-induced pneumonitis: The role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis 18: 243-252, 2001.
133 Kotloff RM, Hansen-Flaschen J, Lipson DA, Tino G, Arcasoy SM, Alavi A, Kaiser LR: Apical perfusion fraction as a predictor of short term functional outcome following bilateral lung volume reduction surgery. Chest 120: 1609-1615, 2001.
f4 National Emphysema Treatment Trial Research Group (Tino, G, member): Patients at high risk of death after lung-volume-reduction-surgery. N Engl J Med 345: 1075-1084, 2001.
ae Arcasoy SM, Tino G: Clinical aspects of obstructive lung disease. Semin Roentgenol XXXVI: 6-11, 2001.
2c